S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis

Qianqian Wang, Jianwei Zheng, June X Zou, Jianzhen Xu, Fanghai Han, Songtao Xiang, Peiqing Liu, Hong Wu Chen, Junjian Wang

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds